Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Jeffrey Michael Sturek, MD

LICENSE # 0101257938
 
Issue Date: 3/23/2015
Expiration Date: 4/30/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 3/2/2022
University Of Virginia School Of Medicine - Charlottesville VA
Rank: Instructor
Years: 2015 - 2016

University Of Virginia School Of Medicine - Charlottesville VA
Rank: Assistant Professor
Years: 2019-present

Academic Appointments - Non-US
Last Updated 3/2/2022
None Reported
Publications
(up to ten in the last five years)
Last Updated 3/2/2022
An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells.
The Journal of Clinical Investigation
Volume: 120
Date: 07 2010
www.jci.org

Subacute loss of vision in one eye - rash on hands and feet - plaques with scaling on genitals - Dx?
The Journal of Family Practice
Volume: 66
Date: 12 2017
www.mdedge.com/jfponline

Quantitative Measurement of IgG to Severe Acute Respiratory Syndrome Coronavirus-2 Proteins Using ImmunoCAP
International Archives of Allergy and Immunology
Volume: 182
Date: 02 2021

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
New England Journal of Medicine
Volume: 384
Date: 03 2021

Variation in Initial U.S. Hospital Responses to the Coronavirus Disease 2019 Pandemic
Critical Care Medicine
Date: 07 2021

IL-13 is a driver of COVID-19 severity
JCI Insight
Volume: 6
Date: 08 2021

Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant
NPJ Vaccines
Date: 11 2021

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
Lancet Infectious Diseases
Date: 12 2021

Convalescent plasma for preventing critical illness in COVID-19: A phase 2 trial and immune profile
Microbiology Spectrum
Volume: 10
Date: 02 2022

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial
Annals of Internal Medicine
Volume: 175
Date: 02 2022